Loading data
ECGNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 3.75 bn USD | 2.85 bn USD | 2.85 bn USD | 2.7 bn USD |
| Cost of revenue | 3.29 bn USD | 2.51 bn USD | 2.53 bn USD | 2.42 bn USD |
| Gross profit | 454.09 m USD | 339.45 m USD | 321.92 m USD | 276.05 m USD |
| Selling, general and administrative expense | 189.34 m USD | 149.54 m USD | 131.38 m USD | 111.4 m USD |
| Operating profit | 264.75 m USD | 189.91 m USD | 190.54 m USD | 164.64 m USD |
| Income tax expense | 72.31 m USD | 49.52 m USD | 45.29 m USD | 40.79 m USD |
| Net income (reported basis) | 201.8 m USD | 143.4 m USD | 137.23 m USD | 124.78 m USD |
| Basic earnings per share | 3.95 USD/share | 2.81 USD/share | 2.69 USD/share | 2.45 USD/share |
| Diluted earnings per share | 3.95 USD/share | 2.81 USD/share | 2.69 USD/share | 2.45 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.